uniQure Stock Hits 18-Month High After FDA Agreement Clears Pathway For Huntington’s Treatment: Retail Gets More Optimistic

Published: 12/10/2024

uniQure Stock Hits 18-Month High After FDA Agreement Clears Pathway For Huntington’s Treatment: Retail Gets More Optimistic

tags

Latest News

NEWS 03.14.2026

Japan Approves Stem-Cell Treatment for Parkinson’s in World First – Newsmax

NEWS 03.14.2026

EMA Aesthetics Announces Strategic Investment in MonoTx and Secures Board Representation, Advancing Regenerative Aesthetics Innovation – The Malaysian Reserve

NEWS 03.14.2026

Dr. Debra Durst Hosts Free Screening of Groundbreaking Film on Women’s Health with Live Discussion – Knoxville News Sentinel

NEWS 03.14.2026

A New RNA Therapy Could Help the Heart Repair Itself (IMAGE) – EurekAlert!